GO:0044819 mitotic G1/S transition checkpoint signaling: Cell Cycle Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044819 (mitotic G1/S transition checkpoint signaling) is a biological process that detects and negatively regulates progression from G1 to S phase during a mitotic cell cycle [1,7].
• The checkpoint integrates cyclin-dependent kinase (CDK) activity, phosphatase regulation (PP2A), and ubiquitin-mediated proteolysis to prevent premature S phase entry [4,7,8].
• Key regulators include CDKN3, SKP2, PP2A subunits, and cyclin/CDK complexes, whose dysregulation is linked to melanoma and other cancers [1,4,7,8].
• The checkpoint is conserved from yeast to humans, with Hsk1 and Clb cyclins controlling S-phase initiation and histone gene repression at G1/S in fission yeast [3,5].
• Tumor suppressor CDKN3 controls mitosis and its loss contributes to chromosomal instability, highlighting the checkpoint's role in genome maintenance.
• Studying this checkpoint requires CRISPR knockout, point mutation, knock-in, and overexpression models combined with cell cycle profiling and phosphoproteomics [1,2,6].
Description
The mitotic G1/S transition checkpoint (GO:0044819) is a cell cycle surveillance mechanism that ensures cells commit to DNA replication only when conditions are favorable and prior events are completed [1,7]. It operates at the boundary between G1 and S phase, negatively regulating the onset of DNA synthesis in mitotic cell cycles [1,7]. This checkpoint is fundamental for maintaining genomic integrity, as its failure allows cells to enter S phase with unrepaired damage or insufficient growth signals, leading to mutations and aneuploidy [1,8]. Research into this process spans yeast, plant, and mammalian systems, revealing conserved kinase and phosphatase networks that control the G1/S switch [3,5,6]. In melanoma and other cancers, dysregulation of G1/S checkpoint components such as CDKN3 and SKP2 drives uncontrolled proliferation [1,4,8]. Understanding the molecular players and regulatory logic of GO:0044819 is therefore critical for cancer biology, developmental studies, and the design of targeted therapies [1,2,7].
mitotic G1/S transition checkpoint signaling At A Glance
| GO ID | GO:0044819 |
|---|---|
| GO term | mitotic G1/S transition checkpoint signaling |
| Ontology | biological_process |
| Synonym | mitotic G1/S transition checkpoint |
| Definition | A cell cycle checkpoint that detects and negatively regulates progression from G1 to S phase as part of a mitotic cell cycle. |
| Major function | Negative regulation of G1-to-S phase progression to ensure genomic integrity and proper cell cycle timing. |
| Key regulators | CDKN3, SKP2, PP2A, cyclin/CDK complexes, Hsk1, Clb cyclins. |
| Conservation | Present in yeast, plants, and mammals, with conserved kinase and phosphatase modules. |
| Disease relevance | Dysregulation linked to melanoma, cancer, and chromosomal instability. |
What Is GO:0044819?
GO:0044819, mitotic G1/S transition checkpoint signaling, is defined as a cell cycle checkpoint that detects and negatively regulates progression from G1 to S phase as part of a mitotic cell cycle. In other words, it is a signaling process that monitors the completion of G1 events and the readiness of the cell for DNA replication, and it can halt or delay the G1-to-S transition when conditions are not met. This checkpoint operates during mitotic cycles and is distinct from other checkpoints such as the G2/M or spindle assembly checkpoints. Its core function is to prevent premature entry into S phase, thereby protecting genome stability [1,7].
Why Is mitotic G1/S transition checkpoint signaling Important in Cell Biology?
The mitotic G1/S transition checkpoint is essential because it acts as a gatekeeper for DNA replication, ensuring that cells do not replicate damaged DNA or divide under unfavorable conditions [1,7]. Loss of this checkpoint leads to genomic instability, a hallmark of cancer, and is frequently observed in melanoma and other malignancies where CDKN3 and SKP2 are altered [1,4,8]. Beyond cancer, this checkpoint coordinates growth signals with cell cycle progression, integrating pathways such as TOR signaling in plants and PP2A-mediated dephosphorylation in mammals [6,7]. Understanding its regulation provides insights into basic cell cycle control and offers therapeutic targets for diseases characterized by uncontrolled proliferation [1,2,8].
• Prevents premature S phase entry, protecting against DNA replication stress and mutations [1,7].
• Integrates growth factor and nutrient signals with cell cycle commitment [4,6].
• Dysregulation is a driver of melanoma and other cancers through CDKN3 and SKP2 [1,4,8].
• PP2A acts as a master regulator of the checkpoint, and its perturbation affects mitosis and G1/S control.
• Conserved in yeast, where Hsk1 and Clb cyclins regulate S phase initiation and histone gene expression [3,5].
• TOR signaling controls cell cycle progression at G1/S in plants, linking metabolism to division.
• CDKN3 tumor suppressor loss causes mitotic defects and chromosomal instability.
• Provides targets for CRISPR-based functional studies and drug discovery in oncology [1,2].
• Mechanical cues and YAP signaling can influence mitotic rounding and division, intersecting with cell cycle checkpoints.
• Experimental models from yeast to cardiomyocytes enable dissection of checkpoint mechanisms [2,3,5].
What Happens During mitotic G1/S transition checkpoint signaling?
Detection of G1/S transition readiness
In simple terms: The cell checks whether it is ready to copy its DNA.
During G1, the cell monitors growth signals, nutrient availability, and DNA integrity. The checkpoint machinery detects whether conditions are appropriate for S phase entry, involving cyclin-dependent kinase (CDK) activity and phosphatase regulation [1,7]. In yeast, Hsk1 kinase is required for proper initiation of S phase and maintenance of mitotic chromosome structures, acting as a sensor for replication competence. The checkpoint negatively regulates progression if errors or stress are detected, preventing premature commitment to DNA synthesis.
Signal transduction to CDK complexes
In simple terms: Signals are relayed to the engines that drive the cell cycle.
Once the checkpoint detects unfavorable conditions, it transduces signals to cyclin/CDK complexes that control G1/S transition. PP2A, a major phosphatase, dephosphorylates key substrates to modulate CDK activity and cell cycle progression. In endothelial cells, Glypican-1 stimulates a Skp2 autoinduction loop that promotes G1/S transition, showing how extracellular cues feed into the checkpoint. The balance between activating phosphorylation by CDKs and inhibitory dephosphorylation by PP2A determines whether the cell proceeds.
Negative regulation and cell cycle arrest
In simple terms: The checkpoint can put the brakes on the cell cycle.
If the checkpoint is activated, it negatively regulates the G1-to-S transition, causing cell cycle arrest. This involves inhibition of CDK activity and stabilization of CDK inhibitors. CDKN3, a tumor suppressor, controls mitosis and its loss leads to mitotic defects, indicating its role in checkpoint enforcement. In fission yeast, Clb cyclins are required to alleviate HIR-mediated repression of histone genes at G1/S, linking checkpoint control to histone supply. The arrest allows time for repair or adaptation before S phase commitment [1,8].
Integration with growth and stress pathways
In simple terms: The checkpoint listens to growth and stress signals.
The G1/S checkpoint integrates inputs from TOR signaling, which controls cell cycle progression in plants and links nutrient status to division. In melanoma, cell cycle regulation is rewired, and checkpoint components are often dysregulated to sustain proliferation. Mechanical cues and YAP signaling can also influence mitotic rounding and adult cardiomyocyte division, intersecting with cell cycle checkpoints. This integration ensures that division occurs only when resources and conditions are suitable [6,2].
Key Genes Involved in GO:0044819 mitotic G1/S transition checkpoint signaling
The following genes and proteins are central to the regulation and execution of the mitotic G1/S transition checkpoint, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDKN3 | Tumor suppressor controlling mitosis and checkpoint enforcement | Loss causes mitotic defects and chromosomal instability; linked to cancer |
| SKP2 | F-box protein mediating ubiquitin-dependent degradation of CDK inhibitors | Autoinduction loop promotes G1/S transition in endothelial cells |
| PP2A subunits | Phosphatase that dephosphorylates cell cycle regulators | Master regulator of cell cycle; modulates G1/S checkpoint |
| Cyclin D/CDK4/6 | Kinase complexes driving G1 progression | Integrate growth signals; targets for cancer therapy |
| Cyclin E/CDK2 | Kinase complexes promoting G1/S transition | Key effectors of checkpoint control |
| Hsk1 | Fission yeast kinase required for S phase initiation | Regulates replication checkpoint and chromosome structure |
| Clb cyclins | Mitotic cyclins in yeast | Alleviate HIR-mediated repression of histone genes at G1/S |
| TOR kinase | Nutrient sensor controlling cell cycle | Links growth signals to G1/S progression in plants |
| YAP | Transcriptional co-activator responding to mechanical cues | Induces mitotic rounding and division in cardiomyocytes |
| Glypican-1 | Cell surface proteoglycan | Stimulates Skp2 autoinduction and G1/S transition |
| CDK inhibitors (p27, p21) | Negative regulators of CDKs | Enforce checkpoint arrest; degraded by SKP2 |
| HIR complex | Histone gene repressor | Represses histone genes at G1/S; alleviated by Clb cyclins |
| Melanoma-associated cell cycle regulators | Various | Dysregulated in melanoma; therapeutic targets |
How Is mitotic G1/S transition checkpoint signaling Regulated?
The mitotic G1/S transition checkpoint is regulated by multiple signaling pathways. PP2A acts as a master regulator, dephosphorylating substrates to control cell cycle progression. TOR signaling integrates nutrient and growth cues to regulate G1/S transition in plants. In endothelial cells, Glypican-1 stimulates a Skp2 autoinduction loop that promotes G1/S transition, linking extracellular matrix signals to checkpoint control. In yeast, Hsk1 kinase and Clb cyclins regulate S phase initiation and histone gene expression, ensuring proper coordination [3,5]. Mechanical cues and YAP signaling can also influence mitotic rounding and division, intersecting with cell cycle checkpoints. These regulatory layers ensure that the checkpoint responds appropriately to diverse physiological conditions.
mitotic G1/S transition checkpoint signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDKN3 | Cancer, chromosomal instability | Knockout in cancer cell lines; xenograft models |
| SKP2 | Melanoma, endothelial proliferation | Overexpression and knockout in endothelial cells [1,4] |
| PP2A subunits | Cancer, mitotic defects | Point mutation and knockout in cell lines |
| Cyclin D/CDK4/6 | Melanoma, breast cancer | Knock-in of mutations; drug resistance models |
| Hsk1 | Replication stress, genome stability | Yeast knockout and point mutation |
Cancer and melanoma
Dysregulation of the mitotic G1/S transition checkpoint is a hallmark of cancer. In melanoma, cell cycle regulation is rewired, and components such as CDKN3 and SKP2 are frequently altered, leading to uncontrolled proliferation [1,4,8]. CDKN3 loss causes mitotic defects and chromosomal instability, promoting tumorigenesis. Targeting checkpoint kinases and phosphatases is a therapeutic strategy in melanoma and other cancers [1,7].
Chromosomal instability and mitotic defects
Failure of the G1/S checkpoint can result in premature S phase entry and DNA damage, contributing to chromosomal instability. CDKN3 tumor suppressor loss leads to mitotic defects, highlighting the checkpoint's role in maintaining genome integrity. PP2A dysfunction also affects mitosis and cell cycle control, further linking checkpoint regulation to chromosomal stability.
Metabolic and growth disorders
The checkpoint integrates nutrient and growth signals via TOR signaling, and its dysregulation may contribute to metabolic disorders characterized by aberrant cell proliferation. In plants, TOR controls cell cycle progression, and similar mechanisms may operate in human cells, linking metabolism to division.
From mitotic G1/S transition checkpoint signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CDKN3 abrogate the G1/S checkpoint? | CRISPR knockout of CDKN3 in cancer cell lines |
| How does SKP2 autoinduction affect G1/S transition? | Overexpression and knockout of SKP2 in endothelial cells |
| What is the role of PP2A phosphorylation sites in checkpoint control? | Point mutation of PP2A subunits via CRISPR |
| How does Hsk1 kinase regulate S phase initiation? | Knockout and tagged knock-in in fission yeast |
| Does YAP overexpression induce mitotic rounding and division? | Overexpression of YAP in adult cardiomyocytes |
| How do Clb cyclins alleviate HIR-mediated repression? | Knockout of Clb cyclins in yeast |
How to Study the mitotic G1/S transition checkpoint signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | DNA content and cell cycle distribution | Assess G1/S arrest after knockout [1,8] |
| EdU/BrdU incorporation | S phase entry | Quantify checkpoint function |
| Phosphoproteomics | Phosphorylation events | Identify CDK/PP2A substrates |
| RNA-seq | Transcriptome changes | Measure histone gene repression |
| Time-lapse microscopy | Mitotic rounding and division | Study YAP effects |
| Western blot | Protein expression and phosphorylation | Validate checkpoint regulators [4,7] |
| Yeast genetics | Growth and replication phenotypes | Dissect Hsk1 and Clb functions [3,5] |
| CRISPR screening | Gene essentiality and synthetic lethality | Identify checkpoint modifiers |
Cell cycle profiling
Flow cytometry and BrdU/EdU incorporation are used to measure G1/S transition and checkpoint arrest. These methods quantify DNA content and S phase entry, allowing assessment of checkpoint function in response to genetic perturbations [1,8].
Phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies substrates of CDKs and PP2A, revealing signaling events at the G1/S checkpoint. This approach can uncover dynamic phosphorylation changes during cell cycle progression.
Transcriptomics
RNA sequencing measures gene expression changes, including histone genes repressed by HIR and alleviated by Clb cyclins at G1/S. It can also reveal pathways affected by checkpoint dysregulation in cancer.
Imaging and live-cell analysis
Time-lapse microscopy and immunofluorescence visualize mitotic rounding, chromosome segregation, and checkpoint protein localization. YAP-induced mitotic rounding in cardiomyocytes is an example of imaging-based analysis.
How CRISPR Can Be Used to Study GO:0044819 mitotic G1/S transition checkpoint signaling
Knockout
CRISPR knockout of checkpoint genes such as CDKN3 or SKP2 allows researchers to assess their requirement for G1/S arrest and cell viability. Knockout cell lines can be used to study drug sensitivity and synthetic lethality [1,8].
Point Mutation
Introducing point mutations in PP2A subunits or CDK phosphorylation sites via CRISPR enables precise dissection of phosphorylation-dependent checkpoint control. This approach avoids confounding effects of complete protein loss.
Knock-in
Tagged knock-in of Hsk1 or cyclin genes with fluorescent or affinity tags facilitates live-cell imaging and proteomic analysis of checkpoint complexes in yeast and mammalian cells [3,5].
Overexpression
CRISPR activation or cDNA overexpression of SKP2 or YAP can model gain-of-function states observed in cancer and cardiomyocyte division, allowing study of checkpoint bypass [2,4].
How EDITGENE Supports mitotic G1/S transition checkpoint signaling Research
Researchers studying mitotic G1/S transition checkpoint signaling-related genes often need to determine whether a candidate gene is causally involved in checkpoint control, and how its perturbation affects cell cycle progression and disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for mitotic G1/S transition checkpoint signaling research.
Frequently Asked Questions About mitotic G1/S transition checkpoint signaling
What is GO:0044819 mitotic G1/S transition checkpoint signaling?
It is a biological process that detects and negatively regulates progression from G1 to S phase during a mitotic cell cycle, ensuring genomic integrity [1,7].
What genes are involved in the mitotic G1/S transition checkpoint?
Key genes include CDKN3, SKP2, PP2A subunits, cyclin/CDK complexes, Hsk1, and Clb cyclins [1,3,4,5,7,8].
How does the G1/S checkpoint prevent cancer?
By halting cell cycle progression when DNA is damaged or conditions are unfavorable, it prevents mutations and uncontrolled proliferation; its loss is linked to melanoma and other cancers [1,8].
What is the role of CDKN3 in the G1/S checkpoint?
CDKN3 is a tumor suppressor that controls mitosis; its loss causes mitotic defects and chromosomal instability.
How does PP2A regulate the G1/S transition?
PP2A is a master phosphatase that dephosphorylates cell cycle regulators to modulate CDK activity and checkpoint control.
What experimental models are used to study GO:0044819?
Models include yeast genetics, mammalian cell lines with CRISPR knockouts, and cardiomyocytes for mechanical studies [2,3,5].
How can CRISPR help study the mitotic G1/S checkpoint?
CRISPR knockout, point mutation, knock-in, and overexpression enable precise perturbation of checkpoint genes to assess their function [1,2,7].
What diseases are associated with G1/S checkpoint dysregulation?
Cancer, particularly melanoma, and chromosomal instability disorders are associated with defects in this checkpoint [1,8].
What methods measure G1/S checkpoint activity?
Flow cytometry, EdU incorporation, phosphoproteomics, and RNA-seq are commonly used [1,5,7].
Is the G1/S checkpoint conserved across species?
Yes, components like Hsk1 in yeast and TOR signaling in plants show conservation of checkpoint mechanisms [3,5,6].
Conclusion
The mitotic G1/S transition checkpoint (GO:0044819) is a critical cell cycle control point that safeguards genome integrity by negatively regulating entry into S phase. Its molecular players, including CDKN3, SKP2, PP2A, and cyclin/CDK complexes, are frequently dysregulated in cancer and other diseases [1,7,8]. Continued research using CRISPR-based models and advanced omics will further elucidate its mechanisms and therapeutic potential [2,4,6].
References
- 1. Xu W et al.. 2016. Cell Cycle Regulation and Melanoma.. Curr Oncol Rep 18(6):34 PMID: 27106898
- 2. Morikawa Y et al.. 2025. YAP Overcomes Mechanical Barriers to Induce Mitotic Rounding and Adult Cardiomyocyte Division.. Circulation 151(1):76-93 PMID: 39392007
- 3. Takeda T et al.. 2001. Regulation of initiation of S phase, replication checkpoint signaling, and maintenance of mitotic chromosome structures during S phase by Hsk1 kinase in the fission yeast.. Mol Biol Cell 12(5):1257-74 PMID: 11359920
- 4. Qiao D et al.. 2012. Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells.. J Biol Chem 287(8):5898-909 PMID: 22203671
- 5. Amin AD et al.. 2012. The mitotic Clb cyclins are required to alleviate HIR-mediated repression of the yeast histone genes at the G1/S transition.. Biochim Biophys Acta 1819(1):16-27 PMID: 21978826
- 6. Ahmad Z et al.. 2019. Cell cycle control by the target of rapamycin signalling pathway in plants.. J Exp Bot 70(8):2275-2284 PMID: 30918972
- 7. Wlodarchak N et al.. 2016. PP2A as a master regulator of the cell cycle.. Crit Rev Biochem Mol Biol 51(3):162-84 PMID: 26906453
- 8. Nalepa G et al.. 2013. The tumor suppressor CDKN3 controls mitosis.. J Cell Biol 201(7):997-1012 PMID: 23775190
